Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 11/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.56 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.49 |
| ▸ | CTSK | P43235 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1318658 | 1.00 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL2769978 | 1.00 | FOLH1 (0.56) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL24945914 | 0.94 | ACE (0.53) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL8215506 | 0.94 | CTSS (0.51) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL20081129 | 0.94 | ACE (0.53) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| Glutamic Acid SCHEMBL2482358 | 0.91 | GRM8 (0.51) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL30853504 | 0.91 | PPARA (0.48) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL3432850 | 0.90 | CTSK (0.51) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL6036315 | 0.90 | CTSK (0.51) | FOLH1NAALAD2RIMKLAPPARGPPARA | |
| SCHEMBL3431559 | 0.90 | CTSK (0.51) | FOLH1NAALAD2RIMKLAPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| CN-119798062-A | Method for catalyzing quinone hydroxylation reaction of alkene by iron | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119798139-A | Method for synthesizing phenolic compound by iron-catalyzed hydroxylation reaction of aromatic compound | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119798083-A | Iron-catalyzed aromatic compound carbon-hydrogen bond hydroxylation nitration method | 南京师范大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119775348-A | Preparation method of polypeptide Angstrom Pi Dalong acetate | 深圳市第二人民医院(深圳市转化医学研究院) | 2025-04-08 | — | — | CN | claimed |
| CN-119751853-A | Aqueous phase green preparation method and application of polyester microspheres | 青岛科技大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119591663-A | Targeting cell surface glycoprotein interaction cross-linking agent and preparation method thereof | 辽宁师范大学 | 2025-03-11 | — | — | CN | claimed |
| CN-116199572-B | Method for alpha-bromination of iron-catalyzed ketone | 南京师范大学 | 2025-01-14 | — | — | CN | claimed |
| CN-119303634-A | Preparation method of nickel-based gel-carbon nitride composite photocatalyst and application of nickel-based gel-carbon nitride composite photocatalyst in CO2Application in reduction | 河北大学 | 2025-01-14 | — | — | CN | claimed |
| CN-115925544-B | Method for ring-opening acrylation of tertiary alcohol through iron catalytic oxidation | 南京师范大学 | 2025-01-14 | — | — | CN | claimed |
| WO-2012150220-A1 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-11-08 | — | — | WO | claimed |
| CN-101538242-B | Synthetic method of Benazepril key intermediate S-amino substance | UNIV ZHEJIANG TECHNOLOGY | 2011-05-25 | — | — | CN | claimed |
| CN-100590068-C | Method for preparing primary amine carbon nano tube | UNIV TONGJI | 2010-02-17 | — | — | CN | claimed |
| CN-101538242-A | Synthetic method of Benazepril key intermediate S-amino substance | UNIV ZHEJIANG TECHNOLOGY | 2009-09-23 | — | — | CN | claimed |
| EP-1542976-B1 | SUBSTITUTED 4-(INDAZOL-3-YL)PHENOLS AS ESTROGEN RECEPTOR (ER) LIGANDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | WYETH CORP (US) | 2009-02-04 | — | — | EP | claimed |
| CN-101177259-A | Method for preparing primary amine carbon nano tube | UNIV TONGJI (CN) | 2008-05-14 | — | — | CN | claimed |
| US-6387890-B1 | CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS; SEXUAL DISORDERS | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2002-05-14 | — | — | US | claimed |
| EP-1049660-A1 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2000-11-08 | — | — | EP | claimed |
| WO-1999019295-A1 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 1999-04-22 | — | — | WO | claimed |
| US-4824974-A | Synthesis for the preparation of 4-amino-4,5-dihydro-2-furancarboxylic acid | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | FOLH1 387/4885NAALAD2 4066/4885RIMKLA 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.